Elixinol Wellness Ltd · ASX:EXL
Elixinol Wellness — FY2025 Earnings Presentation
20 slides from Elixinol Wellness's earnings presentation, Feb 27, 2026
Slide 1: FY25 Annual Report Investor Presentation
1 FY25 ANNUAL REPORT INVESTOR PRESENTATION
Slide 2: Elixinol Wellness: A Sustainable Nutrition & Wellness Company
Elixinol Wellness: A Sustainable Nutrition & Wellness Company Elixinol Wellness operates a vertically integrated business in Australia and the USA producing, manufacturing and distributing a range of complementary products across key verticals including nutrition, wellness and superfood ingredients.
Slide 3: FY25 Financial Results
ELIXINOL WELLNESS (ASX:EXL) FY25 FINANCIAL RESULTS
Slide 4: FY25 Key Highlights
FY25 Key Highlights • FY25 revenue of $15.5m, up 3.6% YoY Repositioned • Solid revenue growth of 8% in Australia, partially offset by weaker US revenue for • Increase in higher-margin e-commerce sales in Australia to $4.3m, up 163% YoY sustainable growth with • Gross margin expansion to 39%, increas
Slide 5: FY25 Operational Highlights
FY25 Operational Highlights • Strong in e-commerce channels • Six new product launches • Commitment to innovation in protein waters and metabolic solutions • Flat performance, compared to unusually strong FY24 • Margin improvement through focus on higher margin products and channels • Well positione
Slide 6: Strategic focus on higher-margin revenue
Strategic focus on higher-margin revenue Revenue Mix FY-25 Revenue Mix FY-24 E-commerce 21.2% • Improved gross margins through 38.4% E-commerce strategic shift towards higher-margin Retail 47.8% categories & channels Retail 54.6% 24.1% Bulk • Gross margins of 39% in FY25 (FY24: 38%) 13.8% Bulk ingre
Slide 7: Structural reduction in cost base and clear path to profitability
Structural reduction in cost base and clear path to profitability Revenue by Quarter ($M) 5.0 • Decrease in operating cost base by approx. 4.0 3.0 30% in Q4 FY25 v Q4 FY24 2.0 • Cost reduction initiatives were accelerated in 1.0 0.0 Q3 FY25 across staffing, marketing & corporate overheads Q1-25 Q2-2
Slide 8: Elixinol Wellness Overview
ELIXINOL WELLNESS (ASX:EXL) OVERVIEW
Slide 9: Elixinol has a bold, ambitious vision for a healthy food roll-up
Elixinol has a bold, ambitious vision for a healthy food roll-up... To build a portfolio of premium- branded health food assets, with Australian manufacturing capabilities and global growth potential. 9 9
Slide 10: Diversified health and nutrition platform built for longevity and everyday wellness
Elixinol Wellness is a diversified health and nutrition platform built for longevity and everyday wellness Nutrition Supplements Superfoods Hemp Foods Australia The Healthy Chef Australian Primary Hemp Mt Elephant Elixinol USA The Super Food Co Soul Seeds 10
Slide 11: Key branding supporting existing and new product introductions
Key branding supporting existing and new product introductions Wholefood Baking Mixes CBD Healthy Savoury Snacking Supplements 11 11
Slide 12: Diversified distribution channels to both B2B and B2C
Diversified distribution channels to both B2B and B2C Retail partners, direct to consumer through e-commerce and white label products Healthy Savoury Snacking 12 12 12 12
Slide 13: Australia is a large & high-growth wellness market
Australia is a large & high-growth wellness market 2024 Value 2030/2033 Forecast Growth/Position Aust Wellness Market1 AUD 160B AUD 307B by 2033 ~7% CAGR Functional Foods AUD 10.5B AUD 16.5B by 2033 ~5% CAGR Dietary Supplements AUD 5.4B AUD 10.4B by 2033 ~8% CAGR Per Capita Health Spend ~AUD 7,402/y
Slide 14: FY26 Strategic Outlook
ELIXINOL WELLNESS (ASX:EXL) FY26 STRATEGIC OUTLOOK
Slide 15: Quantified tailwinds supporting health & wellness spend
Quantified tailwinds supporting health & wellness spend Longevity is reshaping Food-First Wellness is Diversified Product food & nutrition spend embedded in daily life Portfolio Improves Resilience • 70–80% of consumers • Functional foods • Grocery-led wellness rate wellness as high priority growing
Slide 16: EXL is executing against the Wellness Megatrends
EXL is executing against the Wellness Megatrends Accelerate DTC Where Category Leadership Everyday Nutrition Is Growth and Margin Are Compounds as Hemp Where Wellness Scales Highest Grows • DTC delivers faster growth, • Retail wellness categories • Hemp demand grows deeper data and higher remain ear
Slide 17: FY26 Outlook
FY26 Outlook EXL is now operating from a stronger, Operational Cost Growth Strategic more efficient cost Momentum Efficiency Foundation Opportunities base, ready to • Improve • Maintain a • Building a • Pursue value- capture growth performance structurally platform for accretive M&A off a right- low
Slide 18: New Executive management team with broad industry experience
New Executive management team with broad industry experience CEO and CFO appointed in FY25 Natalie Butler Gavin Evans Pauline Gately Executive Director & CEO Non-exec Chair Non-exec Director 25 years industry experience, International business leader with Accomplished Non-Executive Director with pre
Slide 19: Important Notice & Disclaimer
Important Notice & Disclaimer The following material is for general information purposes only and should not be relied on for the making of any investment decision. Any investment in Elixinol Wellness Limited ACN 621 479 794 (Elixinol Wellness) is subject to a number of investment risks including th
Slide 20: Thank-you
Thank-you Elixinol Wellness Limited (ASX:EXL) Gavin Evans, Non-executive Chair Gavin.evans@elixinolwellness.com Katie Mackenzie, Investor Relations kmackenzie@belleviewir.com.au Suite 2, Level 11, 385 Bourke St, Melbourne VIC 3000 info@elixinolwellness.com www.elixinolwellness.com | @EXLWellness